An interventional study of Aggregated data collection and Data collection and qualitative interview in Suicidality and COVID -19, sponsored by Hospices Civils de Lyon. Recruiting at 4 sites in France. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-18.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Suicidal Ideation with a site in France — 11 open to participants now, 13 under way, 1 of them phase 3. Suicidal Ideation · France.
Among the 20 studies in Suicidal Ideation with a site in France, this one has the largest planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2026, is one of 10 with no phase, reaches primary completion later than 10 of the 12 other live ones, and was the 16th registered.
570 studies on the registry are indexed under Suicidal Ideation; 204 are open to participants now.
Browse Suicidal Ideation studies →11 of the 20 studies in Suicidal Ideation with a site in France are open now. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+ · Healthy volunteers
Centre Hospitalier Esquirol · Sites in France
Ages 16–24
Centre Hospitalier Régional d'Orléans · Sites in France
Ages 18+ · Healthy volunteers
Centre Hospitalier Metropole Savoie · Sites in France
Ages 12–65 · Healthy volunteers
Centre Hospitalier Universitaire de Besancon · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 135 Suicidal Ideation studies recruiting now, 52 (39%) set no upper age limit and 79 (59%) stop at 75 or younger; 54 take children under 18; 32 take healthy volunteers.
This study: 8 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 6,500 is above the median of 80 across 470 interventional studies indexed under Suicidal Ideation.
Median enrollment 240 across the 13 interventional studies, 108 across the 7 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 20 has an industry lead sponsor. The 10 most frequent:
Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.
Hospices Civils de Lyon has 1 study filed under Suicidal Ideation — fewer than ten, so there is no comparison to draw.
4 of the studies in Suicidal Ideation with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07305688Centre Hospitalier EsquirolClimate Anxiety in a Young Population at Risk of Suicide | 2027-03-15 |
| NCT07719816Assistance Publique - Hôpitaux de ParisQualitative Study of Student Financial Insecurity and Psychiatry | 2027-06 |
| NCT06921226Centre Hospitalier Metropole SavoieExploratory Analysis of Interpersonal and Intrapersonal Psychological Processes Implied in Risk-taking and Suicidal Behaviors, in Adult and Adolescent At-risk | 2027-06-26 |
| NCT07302295Hospices Civils de LyonAnalysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period | 2027-11 |
Add all 4 to your calendar (.ics) → With an account.
Among the 20 studies in Suicidal Ideation with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.
Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).
Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.
The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The population (subjects and controls) will be divided into age categories:
Subjects with suicidal behavior during the health crisis (Group 1):
Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):
Controls with suicidal behavior before the health crisis (Group 2):
Exclusion Criteria:
- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):
Controls with Suicidal Behavior before the Health Crisis (Group 2):
For Group 1:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
* Name : Group 1 * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022. * Age ≥ 8 years old and \< 18 years old between 2020 and 2022.
Other: Aggregated data collection
* Name : Group 1b * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents * Age ≥ 8 years old and \< 18 years old between 2020 and 2022 for subjects. * One or both parents * Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects). * Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.
Other: Data collection and qualitative interview
* Name: group 2 * Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region * Age ≥ 8 years old and \< 18 years old between 2018 and 2019
Other: Aggregated data collection
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.
Demographic and diagnostic characteristics
The following demographic and diagnostic characteristics will be collected in aggregate form for the entire population of children and adolescents who engaged in suicidal behavior during the health crisis and in the two preceding years: * Age, gender, place of residence, * ICD-10 diagnosis and referral, * Type of suicidal behavior (ideation, self-harm, suicide attempt), * Periods of social restrictions (lockdown, curfew, vaccine pass).
Time frame: Baseline
Number of patients aged 8-17 and 11month admitted to pediatric emergency
Number of patients aged 8-17 and 11month admitted to pediatric emergency rooms or hospitalized in a continuous care/intensive care unit of university hospitals (CHU) or general hospitals (CH) for suicidal behavior during the COVID-19 pandemic period of 2020, 2021, and 2022, and those in the two preceding years: 2018 and 2019.
Time frame: Baseline
Psychopathological and socio-economic characteristics
The following psychopathological and socio-economic characteristics will be collected: * Age, sex, place of residence, * Family situation and intrafamilial relationships * Type of suicidal behavior and description (ideation, self-harm, suicide attempt) * Periods of social restrictions (lockdown, curfew, vaccination pass) * Leisure time and type of leisure activities/hobbies * Education * Relationship with peers * Previous and current psychiatric diagnosis (according to ICD-10) * Personal and family psychiatric history * Personal medical history * Pharmacological and psychological treatment; Type of care
Time frame: Baseline
Scores to CRIES
Scores on the Children's Revised Impact of Events Scale (CRIES-13) (Horowitz et al., 1979; Brunet et al., 2003) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Time frame: Up to 3 months
CAS scale
Scores on the Climate Anxiety Scale (CAS) (Clayton and Karazsia, 2020; Mouguiama-Daouda et al., 2022) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Time frame: Up to 3 months
Qualitative interview
Semi-structured interviews with children and adolescents with suicidal behavior from a representative sample of the cohort. Subjects who agreed to interviews. We will try to have a sample of volunteers from Group 1 who can be representative of our population (care orientation, age, personal psychiatric history, and place of residence.)
Time frame: Up to 3 months
Results to focus groups (parent's subjects, group 1b)
Focus groups with the parents of children and adolescents with suicidal behavior from a representative sample of the cohort (randomly selected).
Time frame: Up to 3 months
Started May 2026 (actual). Primary completion is estimated for Nov 2027, 18 months after the start.
Of 282 non-industry interventional studies with no phase under Suicidal Ideation, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 18 months is below that.
Counting every sponsor, half of 291 studies reached it within 30 months; a quarter within 13 and three quarters within 54.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.